SCHEMBL3101342

SCHEMBL3101342

CCSc1cc(C)c2c(F)cccc2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 1/20 0.43
▸ PARP1 P09874 1/20 0.41
▸ PDE7A Q13946 1/20 0.39
▸ PDE10A Q9Y233 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ MAPT P10636 4/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ LMNA P02545 2/20 0.37
▸ TP53 P04637 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ HTT P42858 1/20 0.37
▸ TSHR P16473 1/20 0.36
▸ HSP90AB1 P08238 1/20 0.36
▸ ACHE P22303 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3094388 0.79 KDM4E (0.48) ELANECYP2C19MAPTKMT2ALMNA
SCHEMBL3093630 0.76 RXFP1 (0.49) ELANEPDE7APDE10ACYP2C9CYP2C19
SCHEMBL20292636 0.75 CYP1A2 (0.50) PARP1CYP2C19MAPTKMT2ALMNA
SCHEMBL3099980 0.71 TSHR (0.46) PDE10ACYP2C9CYP2C19MAPTKMT2A
SCHEMBL3105741 0.71 GAA (0.48) PDE10ACYP2C9CYP2C19MAPTKMT2A
SCHEMBL12804121 0.67 GAA (0.65) ELANECYP2C9CYP2C19MAPTKMT2A
SCHEMBL12803452 0.67 GAA (0.50) ELANECYP2C9CYP2C19MAPTKMT2A
SCHEMBL29077016 0.66 PARP1 (0.50) PARP1PDE10AHSP90AB1ACHEKDM4E
SCHEMBL28270672 0.64 HTR7 (0.41) ELANEPDE7AMAPTKMT2ALMNA
SCHEMBL3111650 0.63 POLB (0.71) CYP2C9CYP2C19MAPTKMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399673-B2 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2013-03-19 — — US disclosed
US-20120252841-A1 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators DRUNENTHAL GMBH (DE) 2012-10-04 — — US disclosed
US-20100234372-A1 SUBSTITUTED 2-MERCAPTOQUINOLINE-3-CARBOXAMIDES AS KCNQ2/3 MODULATORS GRUNENTHAL GMBH (DE) 2010-09-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234372-A1 SUBSTITUTED 2-MERCAPTOQUINOLINE-3-CARBOXAMIDES AS KCNQ2/3 MODULATORS KCNQ1, KCNQ2, KCNJ2 ELANE 4700/4885PARP1 1706/4885PDE7A 2823/4885
US-20120252841-A1 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators KCNQ1, KCNQ2, KCNJ2 ELANE 4700/4885PARP1 1706/4885PDE7A 2823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback